Jun Xue

Hebei North University — China

Medicine · Health Sciences

13h-index669citations54works2.92yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Voice and Speech Disorders(13), Dysphagia Assessment and Management(10), Cancer Genomics and Diagnostics(5), Pancreatic and Hepatic Oncology Research(4), Cancer-related molecular mechanisms research(4)

Publications54 total

Translation element EIF4A1 is a potential divergent immune biomarker between colon cancer and rectal cancer
International Journal of Immunopathology and Pharmacology·2025Open Access
Diagnostic, prognostic, and immunological roles of FUT8 in lung adenocarcinoma and lung squamous cell carcinoma
PLoS ONE·2025· 1 citedOpen Access
Cutaneous Pigment Cell Distributions and Skin Structure of <i>Xenopus</i>
Pigment Cell & Melanoma Research·2025· 1 citedOpen Access
Mismatch Repair Status and Lymph Node Ratio in Survival Prediction of Stage <scp>II</scp>/<scp>III</scp> Rectal Cancer Patients: A Comprehensive Analysis of a Multi‐Center Retrospective Study
Cancer Medicine·2025Open Access
Research Advances in the Construction and Application of Intestinal Organoids.
PubMed·2025
FGF19 is a biomarker associated with prognosis and immunity in colorectal cancer
International Journal of Immunopathology and Pharmacology·2025· 2 citedOpen Access
The burgeoning spatial multi-omics in human gastrointestinal cancers
PeerJ·2024· 6 citedOpen Access
Translation element EIF4A1 is a potential divergent immune biomarker between colon cancer and rectal cancer
2024Open Access
Frequency-mix Knowledge Distillation for Fake Speech Detection
2024· 2 cited
Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study
The Oncologist·2024· 2 citedOpen Access
Frequency-mix Knowledge Distillation for Fake Speech Detection
arXiv (Cornell University)·2024Open Access
Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms
Aging·2024· 2 citedOpen Access
The role of long non-coding RNA in hepatocellular carcinoma
Aging·2024· 22 citedOpen Access
Fruquintinib combined with sintilimab as a second-line therapy for advanced gastric and gastroesophageal junction adenocarcinoma (GC/GEJC): A phase II, single-arm, prospective study.
Journal of Clinical Oncology·2024· 2 cited
Study on the predictive value of Tom1L1 in the efficacy of neoadjuvant chemotherapy for locally progressive mid-low rectal cancer
Research Square (Research Square)·2023Open Access
[Retracted] MicroRNA‑628‑5p inhibits cell proliferation and induces apoptosis in colorectal cancer through downregulating CCND1 expression levels
Molecular Medicine Reports·2023Open Access
KDM4C silencing inhibits cell migration and enhances radiosensitivity by inducing CXCL2 transcription in hepatocellular carcinoma
Cell Death Discovery·2023· 9 citedOpen Access
Abstract LB302: Radiotherapy exposure and baseline gut microbiota predict clinical outcomes of fruquintinib plus sintilimab in microsatellite-stable metastatic colorectal cancer
Cancer Research·2023· 4 cited
Efficacy of peripheral electrical nerve stimulation on improvements of urodynamics and voiding diary in patients with neurogenic lower urinary tract dysfunction: a systematic review and meta-analysis
International Journal of Surgery·2023· 8 citedOpen Access
Identification of an immune subtype-related prognostic signature of clear cell renal cell carcinoma based on single-cell sequencing analysis
Frontiers in Oncology·2023· 2 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Donna S. Lundy(13), Roy R. Casiano(13), Weizheng Liang(7), Weizheng Liang(6), Qingxue Meng(6), Xueliang Wu(6), Hongli Liu(5), Xuejun Zhi(5), Hong Ma(4), Jianli Hu(4), Peng Wang(4), Joseph Evans(3), Fang Lu(3), Tian Li(3), Hewei Xu(3), Zongyao Fan(3), Zhengsen Chen(3), Sicong Zhang(3), Baixin Shen(3), Zhenpeng Zhu(3)